Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Palonosetron manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

8 products found

palonosetron

Vials, injection 0.25 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP
Unavailable markets
Peru , Vietnam
Registered in
Belgium , Germany , United Kingdom
Available for
Licensing with supply, Distribution only
MAs for sale
Belgium , Germany
Comments
MAs available: DE, BE
Manufacturer #16394

Manufacturer usually replies in 12 days

palonosetron

Solution for injection 50 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

palonosetron

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

palonosetron

Solution for injection/infusion 0.25mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

palonosetron

Injection 0.075 mcg, 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

Manufacturer usually replies in 6 days

palonosetron

Solution for injection 0.25 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #15910

Manufacturer usually replies in 12 days

palonosetron

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20511

Manufacturer usually replies in 21 days

netupitant + palonosetron

Tablets 300 mg + 0.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

PALONOSETRON

Palonosetron is a 5-HT3 antagonist, an antinauseant and antiemetic agent. It is used to prevent vomiting and nausea in patients who are on chemotherapy for moderately-emetogenic cancer and for preventing postoperative nausea and vomiting. Palonosetron is specific and selective serotonin 5-HT3 receptor antagonist that is related to other 5-HT3 receptor antagonists, except for structural difference.

Palonosetron is used in intensive care medicine like pneumonia & peritonitis, some diabetes-related foot infections, and as therapy for febrile neutropenia post-chemotherapy. Prolonged infusions can maximize the duration that serum concentration is maintained at a minimum inhibitory concentration of the bacteria causing the infection. As a post-chemotherapy drug, it is given to prevent nausea and vomiting which may occur within 24 hours post-chemotherapy or surgery. It also prevents delayed nausea and vomiting that may occur several days after receiving certain chemotherapies.

Palonosetron is sold under the brand names such as Aloxi Tazocin and Zosyn among others. Helsinn Healthcare SA developed Palonosetron and was approved for this use by the U.S. Food and Drug Administration. It is the most recent 5-HT3 antagonist to enter clinical use and the only drug of its class.

Dosage Forms & Strengths:

Palonosetron is available as an injectable solution in single-use vials of 0.05mg/mL concentrations. For preventing acute Nausea and Vomiting associated with moderately or highly emetogenic chemotherapeutics and for delayed N/V agents, the dose is 0.25 mg, given through IV over 30 seconds, 30 minutes before chemotherapy begins. And for prevention of Postoperative Nausea & Vomiting, the dose is 0.075 mg, administered through an IV infused over 10 seconds immediately before anaesthesia is given.

The price of Palonosetron:

In the USA, the consumers have to pay around $72 for a supply of 2 millilitres of intravenous solution with 0.25 mg of drug in the 2 mL solution. The price for the same supply is significantly cheaper in countries like India, where it costs only USD2.

How does Palonosetron work?

Palonosetron’s actions block serotonin. Serotonin causes vomiting. Palonosetron has a strong binding affinity as 5-HT3 receptor antagonist and little or no affinity for any other receptors. Cancer chemotherapy sees a high incidence of nausea and vomiting, particularly when agents, such as cisplatin, are used.

Finding Palonosetron Manufacturers and Suppliers

The best way to find and gain access to Palonosetron manufacturers and Palonosetron suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Palonosetron can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Palonosetron to work with. You can fine-tune your search results using various filters too, letting you search for Palonosetron from specific countries.